Navigation Links
Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
Date:7/29/2013

Creabilis' proprietary Low Systemic Exposure (LSE) 'topical-by-design' technology. LSE creates molecules optimized for topical applications. Planning for Phase 3 with CT327 is underway, with a clear route to market and an estimated >$800m in peak annual sales.

Creabilis' pipeline also includes CT340, a potent narrow spectrum kinase inhibitor in development for the topical treatment of neuropathic pain, an area of significant unmet medical need. Like CT327, CT340 was developed using the Company's Low Systemic Exposure (LSE) technology. CT340 is IND-ready and first-in-human studies will commence in 2013.

Creabilis is backed by highly respected life science investors Sofinnova Partners, Neomed and AbbVie Biotech Ventures Inc., and is led by an experienced Management team, with over 100 years of combined R&D experience in pharma and biotech, and over 20 drug approvals. Creabilis has corporate and R&D functions in the UK and Italy.

For further information please contact:

Creabilis
Eliot Forster
eforster@creabilis-sa.com
Creabilis Ltd
6 Denne Hill Business Centre
Canterbury CT4 6HD
                   
Citigate Dewe Rogerson
Chris Gardner or Nina Enegren
Tel: +44(0)20-7282-1050
E-mail: nina.enegren@citigatedr.co.uk


'/>"/>
SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Creabilis Appoints Catherine Moukheibir to its Board of Directors
2. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
3. Alexander Proudfoot Appoints Executive Vice President for Life Sciences
4. KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer
5. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
6. Organovo Appoints Tamar D. Howson to Board of Directors
7. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
8. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
9. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
10. Envera Appoints Michael McErlean Fermentation Manager
11. WMIS Appoints Lisa Baird as Next Executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, presented data on the company,s ... Experimental Biology conference in Boston, Massachusetts ... ideal extension of Organovo,s capabilities to 3D bioprint ... pharmaceutical research," said Keith Murphy , Chairman ...
(Date:4/1/2015)... , April 1, 2015  Spherix Incorporated ... committed to the fostering and monetization of intellectual ... a privately held full service global investment bank ... issued an industry note featuring Spherix. ... CFA, a Senior Analyst at Chardan, was published ...
(Date:4/1/2015)... , April 1, 2015 ... developing novel biological drugs to treat cancer, viral ... announce the appointment of Christina Coughlin ... responsible for providing medical and regulatory leadership to ... Dr. Coughlin has extensive experience in ...
(Date:3/31/2015)... , March 31, 2015 Materials ... ,   June 30 2015   ... information products and services and publishing home of Materials ... has launched the Materials in Society  Lecture Series ... the 8 th International Conference on Materials for ...
Breaking Biology Technology:Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4Chardan Capital Issues Industry Note Covering Spherix 2Chardan Capital Issues Industry Note Covering Spherix 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3
... Jan. 12, 2012  Inverseon, Inc., a pharmaceutical company developing ... that while it anticipates that its asthma program will ... cessation as the initial indication for INV102. ... smoking cessation, and also an inhaled COPD program, makes ...
... ANNAPOLIS, Md., Jan. 11, 2012 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, announced today that Eric I. ... Noble Financial Capital Markets Eighth Annual Equity Conference on Tuesday, ... Room/Room 2 at the Hard Rock Hotel, Hollywood Florida.  ...
... Jan. 11, 2012  goBalto, developer of new generation ... completed a FDA 21 CFR Part 11 compliance ... trials application. Tracker,s successful audit will help both ... running clinical trials comply with FDA rules and ...
Cached Biology Technology:Inverseon Focuses on Mucous and Smoking Cessation 2PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012 2goBalto Completes a Successful FDA 21 CFR Part 11 Compliance Audit 2
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Geometry - Global Strategic Business Report" report to their ... Hand Geometry in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts ...
(Date:3/18/2015)... CORAL SPRINGS, Florida , March 18, 2015 ... as well as businesses, new revolutionary smart wallets and apps ... rapid pace.  Companies currently entrenched in the mobile payment industry ... ), Alibaba Group Holding Ltd. (NYSE: BABA ), ... GOOG ) and Facebook Inc. (NASDAQ: ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6
... a study appearing this month in the journal Environmental ... cars, trucks, planes and powerplants cause 13,000 premature deaths in ... data from 2005, the most recent year for which information ... emissions in the country, car and truck exhaust was the ...
... York Doctors at several centers across the U.S. ... determine the effectiveness of high-dose vitamin D supplements for ... to standard therapy with glatiramer acetate (Copaxone, Teva Pharmaceutical ... Society, is being led by Ellen Mowry, MD, MCR, ...
... New data from a number of clinical trials presented ... 2012 provides hope for previously difficult to treat hepatitis ... study of the efficacy and safety of the protease ... HCV genotype 1 (GT1) recurrence after liver transplantation(1), results ...
Cached Biology News:New study links air pollution and early death in the UK 2Drug interactions won't exclude HCV transplant or HIV co-infected patients from treatment 2
... proud to work in collaboration with Pall ... syringe filters in a variety of membrane ... for use on the Caliper TPWII, MultiDose, ... Pricing for our Automation Certified Syringe Filters ...
... against TATA Binding Proteins (TBP). Ascites Antibody ... and recognizes amino acids 41-57 and may ... of TBP occurs. This antibody does ... either as a nuclear extract or as ...
... is the successor to the original DS-U1. The ... the cameras in the Nikon DS camera line ... The DS-U2 transmits information at high speed, and ... hub and mass storage USB 2.0 interfaces. The ...
... The Helios gene gun low-pressure system, ... delivery of biomaterials into cells. The system ... assembly, helium regulator, tubing prep station, syringe ... kit, low-pressure regulator, and instructions. The dimensions ...
Biology Products: